The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it's unclear how ...
The Centers for Medicare & Medicaid Services (CMS) recently orchestrated a $5 billion election-year rescue operation for Democrats to hide the true costs of the Biden-Harris administration's Inflation ...
CMS issued guidance June 11 outlining plans to update its assessment of Medicaid section 1115 demonstration projects. Section 1115 demonstration projects allow states to test approaches for delivering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results